DS AKANBI LIMITED

Executive Summary

DS AKANBI LIMITED operates as a micro-entity within the UK primary healthcare sector, reflecting characteristics of a small, single-provider medical practice. While its financial scale is modest compared to industry peers, its position allows for niche service delivery amid evolving NHS reforms and growing demand for community health services. To enhance competitive standing, the company will need to navigate sector pressures such as workforce constraints and explore growth opportunities through service diversification or partnerships.

View Full Analysis Report →

Company Analysis

This analysis is opinion only and should not be interpreted as financial advice.

DS AKANBI LIMITED - Analysis Report

Company Number: 13550194

Analysis Date: 2025-07-20 15:27 UTC

  1. Industry Classification
    DS AKANBI LIMITED is classified under SIC codes 86900 ("Other human health activities") and 86210 ("General medical practice activities"). These codes place the company squarely within the UK healthcare sector, specifically primary care and ancillary health services. This sector is characterised by high regulatory oversight, reliance on skilled professionals, and a steady demand driven by the NHS and private health consumers. Companies in this space range from small independent practices to large multi-site providers and often operate under micro to medium business scales.

  2. Relative Performance
    DS AKANBI LIMITED is a micro-entity based on its financial metrics (current assets around £9k, net assets £7.3k as of 2024) with a single employee, which is typical for a small, newly established general medical practice or health consultancy. Compared to industry benchmarks, where turnover and asset bases vary widely, DS AKANBI’s financial position is at the lower end, reflective of a startup or sole practitioner model rather than a larger group practice. The net asset growth from £100 in 2023 to £7,320 in 2024 indicates early-stage capitalisation or retained earnings accumulation but remains modest in scale.

  3. Sector Trends Impact
    The UK healthcare sector is currently influenced by ongoing NHS reforms, increasing demand for community and primary care services, and a shift towards integrated care systems. There is also a strong move towards digital health and telemedicine, which may present opportunities or competitive pressures for smaller practices. Additionally, regulatory compliance and workforce shortages (notably GPs) impact operational capacity. DS AKANBI, as a micro entity, may benefit from localised demand and NHS contracts but faces challenges scaling without significant capital or staff increases.

  4. Competitive Positioning
    As a micro private limited company with only one employee and minimal assets, DS AKANBI is positioned as a niche, likely single-provider medical practice or health consultancy. It is neither a sector leader nor a follower of large-scale operators. Its strengths include agility, low overhead, and potential for personalised service. However, weaknesses include limited capacity, scale, and financial resources relative to typical competitors, which often have multiple practitioners, diversified services, and higher turnover. Sustained growth and competitiveness would depend on expanding patient base, service offerings, or entering collaborative NHS frameworks.


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company